Overview

The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the impact of oral rosuvastatin in diabetic polyneuropathy, and the role of lipid peroxidation and nerve growth factor.
Phase:
Phase 2
Details
Lead Sponsor:
Alejandra Guillermina Miranda Diaz
Treatments:
Rosuvastatin Calcium